Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Clinical trial NCT02003222 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02003222
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-19
- Primary completion
- 2023-06-23
- Enrollment
- 488
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.